CDK4 and breast carcinoma: Treatment with CDK4/6 inhibitors can induce senescence in specific cancer cells, including oestrogen receptor (ER)‐positive breast cancer, lung cancer, melanomas and liposarcoma.19, 44, 45, 46, 47, 48